Abstract
The present document contains recommendations for assessment, prevention and treatment of cardiovascular risk for HIV-infected patients. All recommendations were graded according to the strength and quality of the evidence and were voted on by 73 members of the Italian Cardiovascular Risk Guidelines Working Group which includes both experts in HIV/AIDS care and in cardiovascular and metabolic medicine. Since antiretroviral drug exposure represents only one risk factor, continued emphasis on an integrated management is given. This should include prevention and treatment of known cardiovascular risk factors (such as dyslipidaemia, diabetes, insulin resistance, healthy diet, physical activity, avoidance of smoking), but also rational switch of antiretroviral drugs. A rational switch strategy should consider both metabolic and anthropometric disturbances and effectiveness of antiretroviral regimens.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Members of the Italian Cardiovascular Risk Guidelines Working Group are listed in acknowledgments.
Rights and permissions
About this article
Cite this article
Carosi, G., Quiros-Roldan, E., Torti, C. et al. First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-infected Patients in the HAART Era (2006). Infection 35, 134 (2007). https://doi.org/10.1007/s15010-007-6295-5
Received:
Accepted:
DOI: https://doi.org/10.1007/s15010-007-6295-5